Publication: Recomendaciones del Grupo de Psoriasis de la AEDV sobre el manejo de la consulta de psoriasis durante la pandemia por COVID-19
dc.contributor.author | Belinchón, I. | |
dc.contributor.author | Puig, L. | |
dc.contributor.author | Ferrándiz, L. | |
dc.contributor.author | de la Cueva, P. | |
dc.contributor.author | Carrascosa, J.M. | |
dc.contributor.authoraffiliation | [Belinchón,I] Servicio de Dermatología, Hospital General Universitario de Alicante-ISABIAL-UMH, Alicante, España. [Puig,L] Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. [Ferrándiz,L] Servicio de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, España. [de la Cueva,P] Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, España. [Carrascosa,JM] Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTP, Barcelona, España. | |
dc.contributor.group | Grupo de Psoriasis de la AEDV | es_ES |
dc.date.accessioned | 2021-03-26T12:56:36Z | |
dc.date.available | 2021-03-26T12:56:36Z | |
dc.date.issued | 2020 | |
dc.description.version | Yes | es_ES |
dc.format.extent | 3 p. | es_ES |
dc.identifier.citation | Belinchón I, Puig L, Ferrándiz L, de la Cueva P, Carrascosa JM, en nombre del Grupo de Psoriasis de la AEDV. Recomendaciones del Grupo de Psoriasis de la AEDV sobre el manejo de la consulta de psoriasis durante la pandemia por COVID-19. Actas Dermosifiliogr. 2020 Nov;111(9):802-804. | es_ES |
dc.identifier.doi | 10.1016/j.ad.2020.05.004 | es_ES |
dc.identifier.essn | 1578-2190 | |
dc.identifier.issn | 0001-7310 | |
dc.identifier.pmc | PMC7566662 | |
dc.identifier.pmid | 32522413 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/3273 | |
dc.journal.title | Actas Dermo-Sifiliograficas | |
dc.language.iso | spa | |
dc.publisher | AEDV. Editor comercial: Elsevier España S.L.U. | es_ES |
dc.relation.publisherversion | https://www.actasdermo.org/es-linkresolver-recomendaciones-del-grupo-psoriasis-aedv-S0001731020301642 | es_ES |
dc.rights.accessRights | open access | |
dc.subject | COVID-19 | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | Pandemias | es_ES |
dc.subject | Psoriasis | es_ES |
dc.subject | Infecciones por coronavirus | es_ES |
dc.subject | Carta | es_ES |
dc.subject | Dermatología | es_ES |
dc.subject | Teledermatología | es_ES |
dc.subject | Pandemics | es_ES |
dc.subject | Coronavirus infections | es_ES |
dc.subject | Letter | es_ES |
dc.subject | Dermatology | es_ES |
dc.subject | Teledermatology | es_ES |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Economics and Organizations::Organizations::Academies and Institutes | es_ES |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Services Administration::Patient Care Management::Delivery of Health Care::Telemedicine | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Skin Diseases, Papulosquamous::Psoriasis | es_ES |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Dermatology | es_ES |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Venereology | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections | es_ES |
dc.subject.mesh | Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Immune System Phenomena::Immunocompromised Host | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Publication Type::Publication Formats::Letter | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Immunologic Factors | es_ES |
dc.subject.mesh | Medical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spain | es_ES |
dc.title | Recomendaciones del Grupo de Psoriasis de la AEDV sobre el manejo de la consulta de psoriasis durante la pandemia por COVID-19 | es_ES |
dc.title | Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations From the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV) | es_ES |
dc.type | letter | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |